AtonRa Partners’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $218K | Sell |
21,102
-3,125
| -13% | -$32.3K | 0.43% | 104 |
|
|
2023
Q3 | $190K | Sell |
24,227
-5,915
| -20% | -$46.5K | 0.4% | 113 |
|
|
2023
Q2 | $301K | Sell |
30,142
-2,792
| -8% | -$27.9K | 0.47% | 94 |
|
|
2023
Q1 | $292K | Sell |
32,934
-3,994
| -11% | -$35.5K | 0.43% | 105 |
|
|
2022
Q4 | $405K | Sell |
36,928
-9,987
| -21% | -$110K | 0.52% | 84 |
|
|
2022
Q3 | $611K | Sell |
46,915
-2,302
| -5% | -$30K | 0.6% | 77 |
|
|
2022
Q2 | $624K | Buy |
49,217
+1,753
| +4% | +$22.2K | 0.57% | 79 |
|
|
2022
Q1 | $665K | Buy |
47,464
+172
| +0.4% | +$2.41K | 0.36% | 98 |
|
|
2021
Q4 | $1.37M | Buy |
47,292
+7,080
| +18% | +$205K | 0.48% | 76 |
|
|
2021
Q3 | $1.21M | Buy |
40,212
+16,601
| +70% | +$497K | 0.4% | 90 |
|
|
2021
Q2 | $626K | Buy |
+23,611
| New | +$626K | 0.23% | 111 |
|